Rheumatoid Arthritis

Showing NaN - NaN of 178

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)

Completed
  • Rheumatoid Arthritis
  • Phoenix, Arizona
  • +140 more
Jun 7, 2019

Rheumatoid Arthritis, Musculoskeletal and Connective Tissue Diseases Trial in Worldwide (Adalimumab, Placebo)

Completed
  • Rheumatoid Arthritis
  • Musculoskeletal and Connective Tissue Diseases
  • Adalimumab
  • Placebo
  • Tuscaloosa, Alabama
  • +69 more
Jun 6, 2019

Rheumatoid Arthritis Trial in Worldwide (BMS-986142, Placebo, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +103 more
May 2, 2019

Rheumatoid Arthritis Trial in United States (AI-1000 G2, Tocilizumab)

Completed
  • Rheumatoid Arthritis
  • Mesa, Arizona
  • +7 more
Jan 22, 2019

Rheumatoid Arthritis Trial in United States (acalabrutinib, Placebo)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +16 more
Mar 25, 2019

Rheumatoid Arthritis Trial in Puerto Rico, United States (Itacitinib, Itacitinib Placebo)

Completed
  • Rheumatoid Arthritis
  • Palm Desert, California
  • +17 more
Mar 8, 2019

Rheumatoid Arthritis Trial in Worldwide (Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses,

Completed
  • Rheumatoid Arthritis
  • Rituximab-Pfizer (PF-05280586) x 3 courses
  • +2 more
  • Birmingham, Alabama
  • +70 more
Jan 8, 2019

Rheumatoid Arthritis Trial in Worldwide (PF-06410293, Adalimumab)

Completed
  • Rheumatoid Arthritis
  • PF-06410293
  • Adalimumab
  • Gilbert, Arizona
  • +182 more
Jan 18, 2019

Rheumatoid Arthritis Trial in United States (SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway

Completed
  • Rheumatoid Arthritis
  • SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
  • Aventura, Florida
  • +3 more
Dec 26, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-04171327, prednisone, )

Completed
  • Rheumatoid Arthritis
  • Tucson, Arizona
  • +92 more
Dec 12, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-04171327 10 mg, Prednisone Placebo, PF-04171327 25 mg)

Completed
  • Rheumatoid Arthritis
  • PF-04171327 10 mg
  • +5 more
  • Anniston, Alabama
  • +37 more
Nov 30, 2018

Rheumatoid Arthritis Trial in Worldwide (Placebo, PF-06651600)

Completed
  • Rheumatoid Arthritis
  • Northridge, California
  • +29 more
Nov 6, 2018

Rheumatoid Arthritis Trial in Korea, Republic of, Spain, United States (Placebo, dose level 1, dose level 2)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • +4 more
  • Daytona Beach, Florida
  • +7 more
Mar 12, 2018

Rheumatoid Arthritis Trial in Worldwide (GS-9876, Filgotinib, GS-9876 )

Completed
  • Rheumatoid Arthritis
  • DeBary, Florida
  • +18 more
Aug 21, 2018

Rheumatoid Arthritis, Psoriatic Arthritis Trial in United States (Etanercept / Autoinjector A)

Completed
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Etanercept / Autoinjector A
  • Huntsville, Alabama
  • +12 more
Aug 1, 2018

Rheumatoid Arthritis, Plaque Psoriasis Trial in Canada, United States (Etanercept via Autoinjector A, Etanercept via

Completed
  • Rheumatoid Arthritis
  • Plaque Psoriasis
  • Etanercept via Autoinjector A
  • Etanercept via Autoinjector B
  • Huntsville, Alabama
  • +36 more
Aug 1, 2018

Rheumatoid Arthritis Trial in Czechia, United States (INCB028050, Placebo)

Completed
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +48 more
Aug 28, 2018

Rheumatoid Arthritis Trial in Canada, France, United States (Certolizumab pegol, Placebo)

Completed
  • Rheumatoid Arthritis
  • Certolizumab pegol
  • Placebo
  • Huntsville, Alabama
  • +65 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Canada, United States (Certolizumab pegol)

Completed
  • Rheumatoid Arthritis
  • Certolizumab pegol
  • Huntsville, Alabama
  • +39 more
Jul 4, 2018

Rheumatoid Arthritis Trial in United States (Placebo, Certolizumab pegol)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • Certolizumab pegol
  • Birmingham, Alabama
  • +40 more
Jul 4, 2018

Rheumatoid Arthritis Trial in United States (Certolizumab Pegol (CZP))

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol (CZP)
  • Birmingham, Alabama
  • +109 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol + Methotrexate (MTX), Placebo + Methotrexate (MTX))

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol + Methotrexate (MTX)
  • Placebo + Methotrexate (MTX)
  • Birmingham, Alabama
  • +177 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol, Placebo, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol
  • +2 more
  • Birmingham, Alabama
  • +177 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol (CZP), Adalimumab (ADA), Methotrexate (MTX))

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol (CZP)
  • +2 more
  • Birmingham, Alabama
  • +174 more
Jul 4, 2018

Rheumatoid Arthritis Trial in United States (Adalimumab delivered in current syringe, Adalimumab delivered in Physiolis syringe,

Completed
  • Rheumatoid Arthritis
  • Adalimumab delivered in current syringe
  • +3 more
  • Victorville, California
  • +9 more
Jun 1, 2018